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Abstract: Hypopressive exercises have emerged as a conservative treatment option for pelvic floor
dysfunction (PFD). The aim of this study was to compare the effects of an eight-week hypopressive
exercise program to those of an individualized pelvic floor muscle (PFM) training (PFMT) program,
and to a combination of both immediately after treatment and at follow-up assessments at 3, 6 and
12 months later. The study was a prospective, single-centre, assessor-blinded, randomised controlled
trial. Ninety-four women with PFD were assigned to PFMT (n = 32), hypopressive exercises (n = 31)
or both (n = 31). All programs included the same educational component, and instruction about
lifestyle interventions and the knack manoeuvre. Primary outcomes were the Pelvic Floor Distress
Inventory Short Form (PFDI-20); the Pelvic Floor Impact Questionnaire Short Form (PFIQ-7); PFM
strength (manometry and dynamometry) and pelvic floor basal tone (dynamometry). There were no
statistically significant differences between groups at baseline, nor after the intervention. Overall,
women reduced their symptoms (24.41–30.5 on the PFDI-20); improved their quality of life (14.78–21.49
on the PFIQ-7), improved their PFM strength (8.61–9.32 cmH2O on manometry; 106.2–247.7 g on
dynamometry), and increased their pelvic floor basal tone (1.8–22.9 g on dynamometry). These data
suggest that individual PFMT, hypopressive exercises and a combination of both interventions
significantly reduce PFD symptoms, enhance quality of life, and improve PFM strength and basal
tone in women with PFD, both in the short and longer term.
Keywords: hypopressive exercises; adherence; pelvic floor dysfunction; pelvic floor exercise;
physiotherapy; quality of life
1. Introduction
Pelvic floor dysfunction (PFD) is associated with urinary incontinence (UI), pelvic organ prolapse
(POP), anal incontinence (AI), and sexual dysfunction [1]. These conditions are chronic and are associated
with lower quality of life, and reduced physical, social, and mental well-being [2]. Prevalence studies
suggest that between 23.7% to 46.2% of women experience at least one PFD [3,4], confirming that these
distressing problems are common among females. Related risk factors for PFDs include advanced age,
pregnancy, parity, instrumented delivery, high body weight [3–5], chronic cough, and the repeated
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performance of physical exertions that load the pelvic floor [5]. Physical therapy based on pelvic floor
muscle training (PFMT) is the first line of conservative treatment for women with UI [6] and early
stages of POP [7].
Although there is no standardized protocol for PFMT, one-to-one and closely supervised exercises
seem to be the most effective for stress UI [8]. Many physical therapists integrate other training
approaches in the management of women with PFD, including abdominal muscle training and postural
education, in the belief that such training will mitigate repetitive and/or chronic loading on the
pelvic floor [9]. In this context, hypopressive exercises (HEs) have emerged as a treatment option for
PFD; currently HEs are widely prescribed for women with PFD in hospitals and in private practice
settings in France, Belgium, Spain and Latin American countries [10–14]. In 1980, Caufriez developed
a series of thirty-three consecutive HEs which each involved a posture to be performed in different
body positions (standing, kneeling, quadruped, sitting and supine), combined with a hypopressive
manoeuvre, in which the women performed an expiratory apnea (breath hold at end expiration),
while drawing-in their abdomen and opening their rib cage [10–15]. The theoretical aim of HEs is
to lower intra-abdominal pressure, while concurrently increasing the basal tone of the pelvic floor
muscles (PFMs) and deep abdominal muscles without voluntary activation [15].
Recent studies have lent some support to HEs as an intervention for PFDs. There is evidence
that HEs produce the neuromuscular activation of PFM and abdominal muscles, which might lead
to a beneficial effect on PFM endurance in women with PFD [10]. Evidence also suggests that HEs
may increase levator ani muscle thickness [11] and basal tone, and that they reduce UI symptoms [12].
Randomised controlled trials have concluded that HEs do not enhance the beneficial effect of PFMT on
the strength nor cross-sectional area of the PFMs in women with POP [13,14]. Nevertheless, in these
studies the supervision offered by the study physical therapist was limited, the effect of the therapy on
patient-reported symptoms and quality of life quality of life was not assessed, and the treatment effects
were only evaluated in the short-term [13,14], immediately following the intervention.
The efficacy of HEs has not been evaluated in women who report a combination of concurrent
PFDs [3,4], which is the clinical reality for many gynaecological and physiotherapy services.
Furthermore, the longer-term success of HEs has not been evaluated. Lastly, while symptoms return
when women abandon PFMT exercises, the adherence of women to home based HEs is not known [16],
and the minimum exercise dose required to improve or maintain the outcomes [17] through the HE
approach is not known.
Among women with mild PFDs randomised to a PFMT intervention, a HE intervention or a
combined PFMT and HE intervention, we hypothesised that (i) those randomised to the combination
HE and PFMT intervention would demonstrate greater improvements in patient reported outcomes
than those randomised to either intervention alone, (ii) those randomised to the HE intervention (alone
or in combination with PFMT) would demonstrate greater increases in PFM basal tone compared to
those who performed PFMT alone, (iii) those randomised to PFMT (alone or in combination) would
demonstrate greater improvements in PFM strength than those who performed HE alone. Moreover,
since women have been shown to be satisfied with HE [11] in addition to achieving an improved sense
of well-being [12], we hypothesised that women randomised to the HE intervention would report
long-term adherence to the exercise program. Therefore, the aims of the present study were to compare
the improvements in women’s self-reported signs and symptoms of PFD and their associated quality
of life, as well as differences in PFM strength and tone and adherence to a home exercise program
among women with mild PFDs who are randomised to a HEs intervention alone and in combination
with PFMT, compared with PFMT alone as a reference group.
2. Materials and Methods
We carried out a single-centre, randomised, single-blinded, 3-armed parallel group clinical trial
of women referred with PFD to the Physiotherapy in Women’s Health Research Unit of the Alcalá
University (Madrid, Spain), between October 2013 and September 2017. The study was registered at
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ClinicalTrials.gov (NCT02259712) and approved by the Clinical Research Committee of the Principe
de Asturias Hospital (OE20/2013). In all cases, participant consent was obtained, and CONSORT
guidelines were followed.
2.1. Participants
Women who were referred by their general practitioner, urologist, gynaecologist, or midwife
to receive pelvi-perineal physiotherapy to manage signs or symptoms of PFD were invited to
participate. The inclusion criteria were self-reported signs or symptoms of stress or mixed UI, AI,
and/or gynaecologist diagnosis of stage 1 or 2 of POP, according to the POP-Quantification Scheme [1].
The exclusion criteria were: age less than 18 years or over 70 years, pregnancy, pregnancy within the six
months prior to referral, underwent physiotherapy for PFD in the previous year, abdominal or pelvic
surgery in the previous year, only presenting with symptoms of urge UI, urge faecal incontinence
or vaginal pain, concurrent neurological or a psychiatric disease, any medical contraindication to
performing therapeutic exercises, not able to attend treatments or follow-up assessments at 3, 6 and
12 months, or the inability to understand and complete the study questionnaires. Participants who
agreed to participate provided written informed consent prior to entering the study. Prior to the
intervention, each participant was individually assessed (A0).
2.2. Randomization and Blinding
After A0, equal numbers of women were randomised to a pelvic floor muscle training group
(PFMT-G), a hypopressive exercise group (HE-G) or to a combination group (PFMT+HE-G)). A physical
therapist (VPG: PT1), who did not participate in the assessment nor in the intervention, used a computer
randomization scheme (EPIDAT v.3.1, Xunta, Galicia, Spain) to allocate participants consecutively
to each treatment group. Allocation was not revealed until each participant had completed their
baseline assessment, at which time the treating therapist and the participant were informed of their
group assignment. The three programs lasted eight weeks, with two visits of 45 min each per week.
All programs included an educational component where women learned about PFDs and risk factors,
as well as how to perform the knack manoeuvre, contracting their PFMs before and during physical
efforts that are known to increase intra-abdominal pressure, such as coughing, sneezing, laughing or
jumping. The primary outcomes were the impact of PFD (Pelvic Floor Impact Questionnaire Short Form
(PFIQ-7)) and of PFD-related symptoms on quality of life (Pelvic Floor Distress Inventory Short Form
(PFDI-20)). The secondary outcomes were PFM strength measured by manometry and dynamometry,
PFM basal tone measured by dynamometry, and adherence to the home training program 6 and
12 months after the intervention.
2.3. Follow-Up
Initially, four follow-up visits were scheduled: shortly after completing the intervention (A1),
and at 3 (A2), 6 (A3) and 12 (A4) months after A1. The appointments were flexible depending on
participant availability, and women were called and/or sent a message one week before their scheduled
appointment, in order to confirm or change the day/time.
2.4. Interventions
The same physical therapist (BNB: PT2), who had more than five years of experience in the
physiotherapy management of PFD, delivered all interventions, individually and in person. PT1 and
PT2 were the only study members aware of participant’s group allocation.
2.4.1. Pelvic Floor Muscle Training Group (PFMT-G)
Through encouragement, feedback and resistance offered through vaginal palpation in the
lithotomy position, participants performed PFM exercises based on components of the PERFECT
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scheme [18]. At each session, participants were encouraged to achieve ten maximal effort and rapid
contractions lasting 1 s each, to maintain an isometric contraction up to 10 s, and to repeat this sequence
ten times. Goals were adjusted according to participant progression at every session, and if PT2
considered it appropriate, manual resistance was applied to enhance PFM force. Internal palpation
was performed using two fingers inside the vagina and feedback was given based on palpation at the
midline (6 o’ clock), the left side (8 o’ clock) and the right side (4 o’ clock), to teach women to train
all of their PFMs. At any session, if a woman achieved a score < 3 [19] on levator ani testing (LAT),
intravaginal electrical stimulation (using biphasic pulses with frequency = 85 Hz, pulse width = 500 µs
and a train: rest period = 4:8, then using biphasic pulses with frequency = 30 Hz, pulse width = 500 µs
and a train: rest period of 15:10) was used for 15 min during the session to enhance PFM awareness
and contraction. When pain was reported on palpation of the PFMs, local compression was applied to
painful points, and local stretching and eccentric PFM exercises were performed [20].
Following these modalities, exercises were performed in the lithotomy position using a manometry
probe (Phenix USB 2, Vivaltis, Montpellier, France), interfaced with an IBM compatible computer
for biofeedback. The biofeedback system offered different screens to support concentric, isometric,
and eccentric PFM exercises; the specific exercises and the timing were adjusted based on women’s
capacity and were progressed when appropriate. In women with low PFM contraction awareness
(LAT < 3), and in women with large urogenital hiatus, the dynamometry probe, which could be opened
to provide tactile feedback, was used instead of manometry. Women also progressed from manometry
to dynamometry once they were capable of generating pressure while performing the exercises, as more
resistance could be provided by opening the arms of the dynamometer. If women progressed enough,
the last two biofeedback sessions were conducted in a more functional standing position.
After each treatment session, women were instructed to perform one to three sets of 5 to
10 repetitions PFM exercises daily at home, in supine, sitting or standing position, based on their
PERFECT evaluation, daily, between 1 and 3 times per day.
2.4.2. Hypopressive Exercise Group (HE-G)
Women were instructed on HEs described as Hypopressive Abdominal Gymnastics by Caufriez [15].
First, participants learned how to perform the “hypopressive manoeuvre”, which consisted of exhaling
to their expiratory reserve volume, then holding their breath (apnea), and expanding their rib cage,
to draw their abdominal wall inward and cranially without inhalation [10]. Women were asked
to sustain the apnea and rib-cage expansion for approximately 10 s before resuming their normal
breathing. When the participants were capable of performing this manoeuvre in supine, standing and
sitting positions, they were then instructed on the series of “hypopressive postures”. These postures
are described in standing, kneeling, four-point kneeling, sitting and supine positions, using a variety
of upper and lower limb positions [10,15]. While holding the hypopressive posture, the hypopressive
manoeuvre was repeated three times, with a rest breath between repetitions; the entire sequence being
referred to as a HE [10]. Each HE was repeated three times with rest between exercises. Between 5 and
10 HEs were performed within each session based on the participant’s mastery of the exercises and
readiness to progress through the 33 HEs described by Caufriez. The participants were consistently
instructed during each exercise not to voluntarily contract their PFMs nor their abdominal muscles.
Women allocated to this group received feedback on how to perform PFM contractions during the
vaginal palpation assessment performed with PT3, and were instructed to use this contraction prior to
and during tasks that increase intra-abdominal pressure (the knack), but were asked not to perform
any specific PFM exercises.
At the end of each intervention session, women were asked to perform three different HEs at
home, the selection of which was based on participants choice and the PT2 professional opinion of PT2,
the latter based on observing the participant’s mastery of the exercise. Each HE was to be repeated
three times per set, and participants were asked to perform between 1 and 3 sets per day.
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2.4.3. Combination Training Group (PFMT+HE-G)
Women randomised to PFMT+HE-G performed both PFM exercises and HEs. These participants
received the same PFMT intervention as the PFMT group, and were additionally trained to perform
the hypopressive manoeuvre and learned five HEs: two postures in supine, one on four-point kneeling,
and two in standing. To limit performance bias, the duration of the treatment sessions remained the
same in all three groups, therefore the combination group spent half of each session on PFMT and half
on HEs. Nonetheless, PFM contractions were never combined with HEs.
After each intervention session, participants were asked to exercise at home, following the exercise
prescriptions described for each group, alternating between PFMT and HE between days.
2.4.4. Educational Strategy (All Groups)
The educational strategy consisted of instruction, using printed materials and 3-dimensional
anatomical models, on the anatomy of the pelvic floor and the physiology of the pelvic organs. Women
were advised to minimize their risk factors by not gaining weight or smoking, limiting caffeine intake,
optimizing nutritional intake to limit constipation, and avoiding weightlifting and other high impact
sports. They were also instructed on proper toileting habits to avoid straining the pelvic floor and were
taught to use the knack manoeuvre before and during tasks that increase intra-abdominal pressure.
2.5. Physiotherapy Assessment
A different physical therapist, who specialized in women’s health (MTL: PT3), and who remained
blinded to participant group allocation, performed all baseline and follow-up assessments. Participants
were instructed not to reveal their allocation to PT3.
At the baseline assessment (A0), personal data including age, body mass index, physical activity,
and clinical and obstetric history were collected. At A0 and all other assessments, the following
outcomes were collected by PT3:
(1) The PFIQ-7 Spanish version [21] consists of three scales of seven questions, each taken from the
Urinary Incontinence Impact Questionnaire, the Pelvic Organ Prolapse Impact Questionnaire, and the
Colorectal-Anal Impact Questionnaire. The three scales are scored from 0 (least impact) to 100 (greatest
impact) and an overall summary score (0 to 300) describes the impact of PDF on day to day activities.
(2) The PFDI-20 Spanish version [21] measures both pelvic floor symptoms and the degree of
bother and distress associated with those symptoms. The PFDI-20 includes 20 questions and three
scales. Each of the three scales is scored from 0 (least distress) to 100 (greatest distress), again with an
overall score ranging from 0–300 and higher scores indicating lower quality of life. The three scales
include questions taken from the Urogenital Distress Inventory—6 questions, the Pelvic Organ Prolapse
Distress Inventory—6 questions, and the Colorectal-Anal Distress Inventory—8 questions.
(3) PFM function was assessed using three different measurement instruments. Vaginal palpation
was used to score PFM function using the LAT [19,22], which is a subjective evaluation ranging
from 0 to 5, based on a combination of muscle strength and endurance. PFM strength was then
objectively measured with manometry (Peritron, Melbourne, Australia) and intravaginal dynamometry
(Pelvimètre Phenix, Montpellier, France). Three maximum effort PFM contractions were performed
using each device and the mean peak value of the three trials was retained for analysis. For the
manometry, an air-filled probe was used, and for dynamometry, a two-armed speculum was used with
the arms oriented to open in the mid-sagittal plane, but retained in the closed position. Both vaginal
probes were connected to a Phenix USB2 biofeedback system (Vivaltis, Montpellier, France), interfaced
with an IBM compatible computer, and protected by latex or polyethylene covers. Basal tone was
measured (in g) by dynamometry, before measurements of PFM strength were made. The dynamometry
probe was inserted into the vagina with the arms closed, and passive force was measured as women
were asked to completely relax their PFMs [22].
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During the assessment of PFM strength, contraction quality data were recorded based on visual
inspection, including simultaneous contraction of the gluteus maximus, hip adductor and/or abdominal
muscles, and breath holding.
Exercise adherence was evaluated by PT3, who asked participants at A3 and A4 if they were
doing their home exercises, and, if so, how many times per week. She also asked participants if they
had incorporated the knack manoeuvre into their daily activities.
2.6. Data Analysis
We estimated that with a sample size of 33 individuals in each arm we would have 80% power to
detect a between-group difference of 10 points in the change of quality of life score (PFDI-20), assuming
an expected average change in the reference group (PFMT group) of 25 points with a standard deviation
of 20 points, as was observed in a previous study [13].
We summarized categorical variables with proportions and continuous variables with means and
standard deviations (SD). To estimate the average change from baseline to subsequent visits (V1, V2,
V3 and V4) for each of the continuous outcomes (PFIQ-7, PFDI-20, PFM strength, and PFM passive
resistance), we generated separate linear regression models for each visit, adjusting for the values of
that outcome at A0, as indicated in Equation (1):
Yt = B0 + B1Group + B2Y0 + B3(Group*Y0) (1)
where Yt is the variable of interest at follow-up visit t and Y0 is the baseline value of that variable
(both centred at baseline mean E(Y0)). Group is a categorical variable. The coefficient B0 captures the
average difference between visits 0 and t in the reference group. By changing the reference group and
re-estimating the model, we can estimate the effects in each group.
To compare interventions, we tested whether changes in outcomes across the four follow-up visits
were different between groups. We analysed data from all visits together in one repeated-measures
linear regression model, including individual as a random factor (to account for repeated measures)
and visit and intervention group as fixed factors, while the baseline value was included as a covariate
to adjust for regression to the mean. The model also included the interaction between group and
baseline values (see Equation (2)):
Yt = B0 + B1Group + B2Y0 + B3(Group*Y0) + B4Visit | random(id) (2)
Visit and Group were included as categorical variables, with the PFMT-G intervention group
as the reference. Thus, there were two separate B1 coefficients that capture the average differences
between the HE-G and PFMT+HE-G groups and the PFMT-G group across all three follow up visits.
This model has more power than the previous model in equation-1 to detect differences between
groups, because it considers the effect of time (the visit) and the possible regression to the mean from
baseline values (allowing for differential effects of regression to the mean in the different groups).
The adherence to exercises at A3 and A4 was studied by analysing two binary outcomes
(“does exercises at home regularly” and “does the knack”). For each outcome, we used a logistic
regression model with trial arm as a categorical variable and PFMT-G as the reference group.
The variable LAT was also analysed as binary, because its limited scale (0 to 5) clearly broke the
assumptions of normally needed for the linear models above. We compared the proportions of patients
with LAT = 5 at A4 between the three treatment groups, using a logistic regression model as explained
above for the analysis of adherence to exercises. An α = 0.05 was used for all tests.
3. Results
In total, 99 women were included in the study. Two women could not complete the intervention
because they became pregnant and three other participants did not complete the follow-up and had
no final assessment. None of these five participants’ data were included in the final analysis. In the
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end, 94 participants completed the intervention and follow-up visits, n = 32 in the PFMT-G, n = 31 in
the HE-G, and n = 31 in the PFMT+HE-G (see flow diagram in Figure 1). Clinical and demographic
characteristics at baseline are shown in Table 1.J. Clin. Med. 2020, 9, x FOR PEER REVIEW 7 of 18 
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Characteristics PFMT group (n = 32) 
HE group 
(n = 31) 
PFMT+HE group 
(n = 31) 
Total sample 
(n = 94) 
Age years, (SD) 48 (12) 48 (8) 46 (8) 47 (10) 
BMI kg/m2, (SD) 24.39 (4.77) 24.63 (3.72) 26.21 (4.73) 25.07 (4.47) 
Menopause, n (%) 14 (44%) 10 (32%) 10 (32%) 34 (36%) 
Parity, (SD) 2 (1) 2 (1) 2 (1) 2 (1) 
Smoking, n (%) 2 (6.3%) 8 (25.8%) 7 (22.6%) 17 (18.1%) 
High blood pressure, n (%) 2 (6.3%) 2 (6.5%) 2 (6.5%) 6 (6.4%) 
Depression, n (%) 4 (12.5%) 3 (9.7%) 7 (22.6%) 14 (14.9%) 
Respiratory disease, n (%) 3 (9.4%) 8 (25.8%) 3 (9.7%) 14 (14.9%) 
Constipation, n (%) 10 (31.3%) 14 (45.2%) 10 (32.3%) 34 (36.2%) 
Physical activity, n (%) 24 (75%) 24 (77.4%) 21 (67.7%) 69 (73.4%) 
Pelvic floor dysfunction    94 (100%) 
UI, n (%) 27 (84.4%) 26 (83.9%) 26 (83.9%) 79 (84.0%) 
AI, n (%) 13 (56.3%) 17 (54.8%) 9 (29.0%) 44 (46.8%) 
POP, n (%) 13 (40.6%) 11 (35.5%) 19 (61.3%) 43 (45.7%) 
Previous PF surgery, n (%) 3 (9.4%) 4 (12.9%) 1 (3.4%) 8 (8.5%) 
PFDI-20 total, (DE) 71.71 (45.22) 70.20 (35.23) 69.19 (51.62) 70.38 (44.08) 
POPDI, (SD) 18.49 (14.58) 17.61 (14.34) 22.45 (21.05) 19.50 (16.87) 
CRADI, (SD) 16.51 (18.26) 20.47 (14.57) 14.22 (12.07) 17.06 (15.27) 
UDI,  (SD) 36.72 (21.93) 32.12 (21.44) 32.53 (25.22) 33.82 (22.76) 
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BMI kg/m2, (SD) 24.39 (4.77) 24.63 (3.72) 26.21 (4.73) 25.07 (4.47)
Menopause, n (%) 14 (44%) 10 (32%) 10 (32%) 34 (36%)
Parity, (SD) 2 (1) 2 (1) 2 (1) 2 (1)
Smoking, n (%) 2 (6.3%) 8 (25.8%) 7 (22.6%) 17 (18.1%)
High blood pressure, n (%) 2 (6.3%) 2 (6.5%) 2 (6.5%) 6 (6.4%)
Depression, n (%) 4 (12.5%) 3 (9.7%) 7 (22.6%) 14 (14.9%)
Respiratory disease, n (%) 3 (9.4%) 8 (25.8%) 3 (9.7%) 14 (14.9%)
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Pelvic floor dysfunction 94 (100%)
UI, n (%) 27 (84.4%) 26 (83.9%) 26 (83.9%) 79 (84.0%)
AI, n (%) 13 (56.3%) 17 (54.8%) 9 (29.0%) 44 (46.8%)
POP, n (%) 13 (40.6%) 11 (35.5%) 19 (61.3%) 43 (45.7%)
Previous PF surgery, n (%) 3 (9.4%) 4 (12.9%) 1 (3.4%) 8 (8.5%)
PFDI-20 total, (DE) 71.71 (45.22) 70.20 (35.23) 69.19 (51.62) 70.38 (44.08)
POPDI, (SD) 18.49 (14.58) 17.61 (14.34) 22.45 (21.05) 19.50 (16.87)
CRADI, (SD) 16.51 (18.26) 20.47 (14.57) 14.22 (12.07) 17.06 (15.27)
UDI, (SD) 36.72 (21.93) 32.12 (21.44) 32.53 (25.22) 33.82 (22.76)
PFIQ-7 V0 total, (SD) 45.39 (43.71) 32.26 (31.36) 35.48 (28.57) 37.79 (35.34)
POPIQ, (SD) 11.16 (16.96) 7.68 (12.94) 9.37 (13.72) 9.42 (14.58)
CRAIQ, (SD) 11.31 (18.09) 4.15 (9.18) 4.91 (8.65) 6.84 (13.07)
UIQ, (SD) 22.92 (19.52) 20.43 (19.87) 21.20 (19.02) 21.53 (19.29)
LAT grade
0, n (%) 3 (9.4%) 1 (3.2%) 3 (9.7%) 7 (7.4%)
1, n (%) 4 (12.5%) 2 (6.5%) 6 (19.4%) 12 (12.8%)
2, n (%) 5 (15.6%) 2 (6.5%) 4 (12.9%) 11 (11.7%)
3, n (%) 15 (46.9%) 15 (48.4%) 11 (35.5%) 41 (43.6%)
4, n (%) 4(12.5%) 10 (32.3%) 7 (22.6%) 21 (22.3%)
5, n (%) 1 (3.1%) 1 (3.2%) 0 (0.0%) 2 (2.1%)
Manometry cmH2O, (SD) 16.51 (14.19) 22.87 (15.92) 18.0 (13.86) 19.11 (14.76)
Dynamometry g, (SD) 239.16 (216.10) 370.20 (307.03) 268.74 (216.63) 293.55 (254.57)
Basal tone g, (SD) 206.67 (17.80) 204.13 (13.70) 200.47 (15.73) 203.76 (15.84)
Nearby muscles
contraction, n (%) 27 (84.4%) 23 (74.2%) 25 (77.4%) 74 (78.7%)
Apnea during PFM
contraction, n (%) 27 (84.4%) 17 (54.8%) 25 (80.6%) 69 (73.4%)
PFMT: Pelvic floor muscle training; HE: Hypopressive exercises; PFMT+HE: Pelvic floor muscle training and
hypopressive exercises; n: Number; SD: Standard deviation; BMI: Body mass index; UI: Urinary incontinence;
AI: Anal incontinence; POP: Pelvic organ prolapse; PF: Pelvic floor; PFDI-20: Pelvic floor Distress Inventory Short
Form; POPDI: Pelvic organ prolapse distress inventory; UDI: Urinary distress inventory; CRADI: Colo-rectal-anal
distress inventory; PFIQ-7: Pelvic Floor Impact Questionnaire Short Form; POPIQ: Prolapse impact questionnaire;
CRAIQ: Colo-rectal-anal impact questionnaire; UIQ: Urinary impact questionnaire; LAT: Levator Ani Testing; PFM:
Pelvic floor muscles. There were no found significant differences between groups.
Table 2 shows the average differences from baseline to each follow-up visit, for each outcome
of interest and for each intervention group. The mean differences were estimated after adjusting for
baseline values, as described in Equation (1). For most of the outcomes at most follow-up visits, the 95%
confidence intervals did not include “0”, indicating 95% confidence that a true change in that outcome
occurred relative to baseline. The intervals that included the null are highlighted in bold font. For
the main quality of life outcomes (PFDI-20 and PFIQ-7) the confidence intervals did not include 0
(see Figure 2).
Regarding PFM function outcomes, women in all three groups improved their PFM strength
measured both by manometry and dynamometry (Table 2); whereas tone increased at A2 in PFMT-G
and HE-G, at A3 in PFMT+HE-G and at A4 in all groups (Figure 3). Only two patients had LAT = 5 at
baseline, while 44 patients (47%) had LAT = 5 at visit A4, with a similar proportion in the three trial
arms (50% in the PFMT group, and 45% in each of the two other groups). These differences between
the groups are not statistically significant (p-value from a X2 test of homogeneity is 0.91).
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Table 2. Average changes for each outcome between baseline measurement and different periods
(adjusted by baseline).
Variable To
PFMT Group HE Group PFMT+HE Group
Mean 95%CI Mean 95%CI Mean 95%CI
PFDI-20 A1 −30.55 (−40.70 to −20.39) −32.17 (−42.48 to −21.86) −24.41 (−34.72 to −14.09)
PFDI-20 A2 −35.07 (−46.63 to −23.52) −34.30 (−46.03 to −22.57) −25.24 (−36.98 to −13.50)
PFDI-20 A3 −39.49 (-49.86 to −29.11) −40.80 (−51.34 to −30.27) −24.71 (−35.25 to −14.17)
PFDI-20 A4 −41.70 (−51.61 to −31.78) −41.69 (−51.76 to −31.62) −25.77 (−35.85 to −15.69)
POPDI A1 −7.95 (−11.83 to −4.07) −9.07 (−13.04 to −5.10) −5.82 (−9.79 to −1.84)
POPDI A2 −8.24 (−12.84 to −3.63) −8.49 (−13.20 to −3.78) −4.75 (−9.46 to −0.03)
POPDI A3 −9.44 (−13.22 to −5.66) −10.84 (−14.71 to −6.98) −6.77 (−10.64 to −2.90)
POPDI A4 −13.11 (−16.94 to −9.29) −10.58 (−14.49 to −6.67) −6.10 (−10.02 to −2.18)
CRADI A1 −5.91 (−9.42 to −2.40) −7.28 (−10.95 to −3.62) −3.21 (−6.87 to 0.46)
CRADI A2 −7.54 (−11.58 to −3.49) −6.53 (−10.75 to −2.30) −5.50 (−9.73 to −1.28)
CRADI A3 −9.44 (−12.74 to −6.15) −8.72 (−12.16 to −5.28) −5.76 (−9.21 to −2.32)
CRADI A4 −8.17 (−11.66 to −4.67) −9.57 (−13.22 to −5.92) −4.21 (−7.86 to −0.56)
UDI A1 −15.83 (−21.45 to −10.22) −15.74 (−21.41 to −10.06) −15.11 (−20.77 to −9.44)
UDI A2 −21.06 (−26.44 to −15.69) −17.03 (−22.46 to −11.60) −14.62 (−20.04 to −9.20)
UDI A3 −20.30 (−25.82 to −14.77) −21.21 (−26.80 to −15.63) −12.99 (−18.56 to −7.42)
UDI A4 −20.57 (−25.29 to −15.84) −21.44 (−26.21 to −16.67) −15.77 (−20.54 to −11.01)
PFIQ-7 A1 −21.49 (−30.60 to −12.38) −18.73 (−28.00 to −9.47) −14.78 (−23.93 to −5.64)
PFIQ-7 A2 −26.14 (−34.83 to −17.45) −25.01 (−33.84 to −16.18) −12.21 (−20.93 to −3.48)
PFIQ-7 A3 −26.6 (−33.46 to −19.74) −26.17 (−33.14 to −19.19) −18.50 (−25.39 to −11.62)
PFIQ-7 A4 −26.69 (−33.79 to −19.58) −23.22 (−30.44 to −16.00) −14.41 (−21.55 to −7.28)
POPIQ A1 −5.57 (−9.86 to −1.27) −5.01 (−9.39 to −0.63) −2.96 (−7.30 to 1.38)
POPIQ A2 −7.92 (−11.94 to −3.90) −6.29 (−10.39 to −2.19) −2.03 (−6.09 to 2.04)
POPIQ A3 −7.30 (−10.15 to −4.45) −6.16 (−9.07 to −3.26) −4.03 (−6.91 to −1.15)
POPIQ A4 −6.88 (−9.68 to −4.09) −6.02 (−8.87 to −3.17) −2.02 (−4.84 to 0.81)
CRAIQ A1 −5.17 (−8.49 to −1.86) −3.98 (−7.39 to −0.57) −3.05 (−6.39 to 0.30)
CRAIQ A2 −5.36 (−9.11 to −1.61) −4.49 (−8.34 to −0.63) −0.14 (−3.93 to 3.65)
CRAIQ A3 −5.65 (−7.78 to −3.53) −4.81 (−7.00 to −2.62) −2.53 (−4.68 to −0.38)
CRAIQ A4 −6.01 (−8.05 to −3.97) −2.35 (−4.45 to −0.26) −1.04 (−3.10 to 1.02)
UIQ A1 −11.05 (−15.13 to −6.97) −10.9 (−15.04 to −6.75) −10.13 (−14.27 to −6.00)
UIQ A2 −13.45 (−17.19 to −9.70) −14.31 (−18.11 to −10.51) −11.18 (−14.97 to −7.39)
UIQ A3 −13.70 (−17.30 to −10.10) −15.00 (−18.65 to −11.35) −12.48 (−16.13 to −8.83)
UIQ A4 −13.40 (−17.61 to −9.19) −14.75 (−19.02 to −10.48) −10.55 (−14.81 to −6.28)
Manometry A1 9.32 (6.03 to 12.61) 8.70 (5.37 to 12.03) 8.61 (5.41 to 11.80)
Manometry A2 9.36 (5.97 to 12.75) 7.10 (3.67 to 10.53) 10.12 (6.83 to 13.41)
Manometry A3 9.30 (5.88 to 12.71) 7.25 (3.80 to 10.70) 8.50 (5.19 to 11.82)
Manometry A4 9.31 (5.44 to 13.18) 8.46 (4.55 to 12.37) 9.88 (6.12 to 13.63)
Dynamometry A1 247.68 (175.12 to 320.23) 106.18 (35.12 to 177.23) 153.84 (85.02 to 222.65)
Dynamometry A2 225.28 (154.72 to 295.84) 121.12 (51.74 to 190.49) 132.80 (63.98 to 201.62)
Dynamometry A3 225.80 (141.85 to 309.76) 152.09 (68.36 to 235.83) 149.98 (68.10 to 231.87)
Dynamometry A4 216.68 (132.01 to 301.34) 181.80 (98.56 to 265.05) 174.22 (91.65 to 256.80)
Basal tone A1 −0.2 (−3.74 to 3.34) 3.31 (−0.09 to 6.71) 1.83 (−1.64 to 5.31)
Basal tone A2 4.09 (0.27 to 7.91) 7.6 (3.90 to 11.30) 2.12 (−1.72 to 5.97)
Basal tone A3 8.61 (−7.32 to 24.54) 6.73 (−8.97 to 22.43) 22.87 (6.82 to 38.91)
Basal tone A4 9.08 (5.58 to 12.59) 8.47 (5.07 to 11.86) 6.53 (3.00 to 10.06)
PFMT: Pelvic floor muscle training; HE: Hypopressive exercise; PFMT+HE: Pelvic floor muscle training and
hypopressive exercise; CI: Confidence Interval; PFDI-20: Pelvic floor Distress Inventory Short Form; POPDI:
Pelvic organ prolapse distress inventory; UDI: Urinary distress inventory; CRADI: Colo-rectal-anal distress
inventory; PFQ−7: Pelvic Floor Impact Questionnaire Short Form; POPIQ: Prolapse impact questionnaire; CRAIQ:
Colo-rectal-anal impact questionnaire; UIQ: Urinary impact questionnaire. The mean and CI that did not show
significant differences against A0 are highlighted in bold.





Figure 2. (A): changes in PFDI-20: Pelvic floor Distress Inventory Short Form outcome from baseline; (B): changes in PFIQ-7: Pelvic Floor Impact Questionnaire Short
Form outcome from baseline.




Figure 3. (A): changes in pelvic floor muscle strength measured by manometry outcome from baseline; (B): changes in pelvic floor muscle strength measured by
dynamometry outcome from baseline; (C): changes in basal tone outcome from baseline.
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Table 3 shows the coefficients for the average difference between groups across all three visits for
the different outcomes (estimated using Equation (2)). Only three variables were significantly different
(p < 0.05) and the primary outcomes (PFDI-20 and PFIQ-7) did not show significant differences.
Table 3. Mean differences between intervention groups across 4 follow-up assessments.
Variable
(HE-G)–(PFMT-G) (PFMT+HE-G)–(PFMT-G)
Mean Diff. p-Value Mean Diff. p-Value
PFDI-20 −0.54 0.9326 11.67 0.0703
POPDI −0.06 0.9785 3.83 0.0935
CRADI −0.26 0.9040 3.09 0.1535
UDI 0.59 0.8503 4.82 0.1233
PFIQ-7 1.95 0.6675 10.25 0.0248
POPIQ 1.05 0.6175 4.16 0.0485
CRAIQ 1.64 0.2768 3.86 0.0110
UIQ −0.84 0.7119 1.81 0.4260
Manometry −1.44 0.5280 −0.04 0.9844
Dynamometry −86.07 0.0887 −72.63 0.1481
Basal tone 1.04 0.7721 2.87 0.4333
PFMT-G: Pelvic floor muscle training group; HE-G: Hypopressive exercise group; PFMT+HE-G: Pelvic floor muscle
training and hypopressive exercise group; diff: Difference; PFDI-20: Pelvic floor Distress Inventory Short Form;
POPDI: Pelvic organ prolapse distress inventory; UDI: Urinary distress inventory; CRADI: Colo-rectal-anal distress
inventory; PFIQ-7: Pelvic Floor Impact Questionnaire Short Form; POPIQ: Prolapse impact questionnaire; CRAIQ:
Colo-rectal-anal impact questionnaire; UIQ: Urinary impact questionnaire. Average differences between groups that
showed p-values < 0.05 are highlighted in bold.
Some adverse effects were found in the three intervention groups. One woman in the PFMT+HE-G
reported that the exercises exacerbated back pain, so the exercises were adapted to lower the intensity
and number of sets, and five women who were instructed in HEs, needed the postures adapted because
they could not do them correctly or they caused pain when performing them as instructed (which was
as described by Caufriez).
Adherence to the home exercises reported in A3 was similar across the groups; PFMT-G had
23 (71.9%) adherence, HE-G had 19 (61.3%) adherence and PFMT+HE-G had 21 (67.7%) adherence,
in terms of exercising weekly at home. By A4 adherence fell below 60% (56.3%, 54.8%, and 48.4%
in PFMT-G, HE-G and PFMT+HE-G respectively) in all three treatment groups, with no significant
differences between groups. The knack manoeuvre was incorporated into activities of daily life in
approximately 85% of participants, with no significant differences found between groups. Again, some
reduction in the performance of the knack was observed at A4 (68.8%, 83.9%, and 80.6% in PFMT-G,
HE-G and PFMT+HE-G respectively), again with no significant differences between groups.
4. Discussion
To our knowledge, this is the first study to test the efficacy of HEs alone, or in combination
with PFMT, against PFMT in order to determine the efficacy of these exercises, in relation to the gold
standard for conservative intervention. The findings from this study suggest that, when delivered in
conjunction with education and advice to perform the knack manoeuvre, a physiotherapy treatment
focused on PFMT, HEs or a combination of PFMT+HEs all reduce PFD symptoms, improve condition
specific quality of life, and achieve an enhancement in PFM function. As the goal of the treatment
for PFD is to maintain improvements over the long term, we investigated both the maintenance
of improvements after the end of the eight-week supervised protocol, as well as adherence to the
home exercise program after the intervention was discontinued. We found that improvements were
maintained, and adherence to the exercises and to the knack was high, as 97 women completed the
intervention, 94 participants attended the four follow-ups, and 50 women continued to practice the
exercises at home, 12 months after the treatment ended.
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While no significant differences were found between the study groups, all groups improved in terms
of their symptoms; some limitations in terms of the interpretation of these findings must be considered.
Firstly, the three groups received the same lifestyle advice, which has itself demonstrated effectiveness
in reducing symptoms associated with mild PFD [23]. Second, all women were instructed on the
knack manoeuvre, and its value when incorporating it into activities where rises in intra-abdominal
pressure are experienced. This approach has also demonstrated effectiveness as a means of reducing or
preventing urine leakage [24]. Indeed, with the high adherence to “the knack”, the improvements in
PFM strength may have been the result of a training effect induced by performing this manoeuvre.
Nevertheless, our intervention approaches were designed in accordance with current physiotherapy
practice, where therapeutic exercise is accompanied by education and advice.
The treatment effect was determined as the difference in the mean change in PFDI-20 and PFIQ-7
scores among groups. Barber et al. [25] considered a change of 45 points or more in the summary score
of the PFDI-20 and 36 points or more in the PFIQ-7 to be the minimal clinically important difference in
women undergoing surgery for PFD. Based on our results, participants improved between 24.4 and
41.7 points in the PFDI-20, and between 14.4 and 26.7 in the PFIQ-7, and as such, the changes seen with
the interventions as delivered may not have been clinically important. These small differences may be
due to our sample, including women with mild PFD in whom surgery was not indicated, which may
have resulted in lower PFDI-20 and PFIQ-7 scores at baseline. In fact, the changes observed in the
current study were higher than those observed in the PFMT group of Wiegersma et al. [26], where an
improvement of 11 points on the PFDI-20 and 2.6 points on the PFIQ-7 was found in women with
mild POP.
Consistent with our results, previous studies have found that supervised PFMT, including
biofeedback and electrical stimulation with voluntary PFM contractions, successfully improved the
symptoms of UI [27] and mild POP [28]. PFMT without feedback devices has also demonstrated
improvements in PFM strength [28] and hypertrophy of the urethral sphincter [27]. Based on our
results, although the PFM strength increase was higher in the PFMT group, there were no statistically
significant differences between the strength increase in the PFMT-G and that observed in the HE-G
and the combined exercise group, as we hypothesised. The addition of HE to a PFMT protocol
was previously tested in women with POP-Q stage 2 [13,14] and there were no differences between
the PFMT group, and the PFMT+HE group; while PFMT was superior in terms of improving PFM
endurance [13]. However, in [13,14], participants only received three supervised session, and PFM
contractions were added to HEs, while in our study, all participants received sixteen individual
sessions and HEs were trained according to their original description [10–15], that is, without voluntary
contraction of the PFMs.
The efficacy of a HE training protocol alone or in addition to PFMT has not previously been
demonstrated [29], in terms of signs, symptoms, quality of life, PFM strength or PFM basal tone in
women with PFD. Our study suggests that a physiotherapy treatment based on HE may be as effective
as a PFMT protocol. Hung et al. [9] proposed a treatment based on a coordinated retraining of the
diaphragm, the deep abdominal muscles and the PFMs, and demonstrated positive results in women
suffering from stress and mixed UI. Although the contraction of the deep abdominal muscles has been
identified to occur synergistically to enhance PFM contraction in healthy women [30], it is necessary
to measure what happens in women with PFD. When an abdominal muscle contraction causes an
increase in intra-abdominal pressure, without an effective PFM activation, a downward movement of
the bladder and pelvic floor have been noted [31]. This consequence may strain the connective tissue
and/or enlarge the urogenital hiatus. Thus, HEs may be a safe alternative to training the PFMs and
abdominal muscles [10], and abdominal muscles while protecting the pelvic floor.
In HEs, the abdominal muscles are not voluntarily activated, and the diaphragm is thought
to maintain a shortened position (i.e., end expiration), which theoretically reduces intra-abdominal
pressure. While this mechanism has not been demonstrated empirically, in a study using transabdominal
ultrasound, it was demonstrated that HEs elevate the PFMs without a direct contraction command [32],
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and that both the size and the strength of the PFMs were strengthened in the postpartum period in
women who performed them for two months, in small groups, for 45 to 60 min, once per week [11].
Furthermore, it was recently observed that HEs recruit the PFMs to 74.4%–86.5% of their maximum
electromyography activation and generate vaginal closure forces between 51.2%–55.7% of the maximum
observed during voluntary contraction [10]. Thus, HEs may provide a PFM training stimulus without
voluntary PFM contraction.
However, as noted above, to perform the knack manoeuvre correctly, the PFMs must contract
voluntarily, which may mean that the HEs were not the stimulus underlying the improvements in
PFM strength, nor the improved symptoms in women with PFD randomized to the HE-G int his study.
In this study sample, 7 (7.4%), women demonstrated no motion of the PFMs while trying to contract
them (LAT = 0), while 23 (24.6%) achieved a flicker or weak PFM action with no cranial movement of
the PFMs (LAT < 3), which suggests that overall, 32% of our sample did not know how to contract their
PFMs correctly. All participants were provided feedback through manual palpation on how to contract
their PFMs, which may have resulted in positive feedback [33], which is a predictor of success with
exercise interventions [34]. Therefore, the success of our interventions, apart from the three exercise
protocols, might have been due to the instructions on the knack manoeuvre, feedback provided during
intra-vaginal assessments, the intensive protocol, and the individualized and close follow-up.
Soriano et al. [12] did not identify any negative events associated with HEs, although blood
pressure was monitored, and participants were asked about respiratory or cardiovascular complications
during the treatment. In our study, the appearance of low back pain was identified in five patients,
which was resolved in all cases by simplifying the HE postures.
The initial adherence with the treatment was high, where 94 out of 99 participants completed the
intensive 2-month intervention and returned for the 12-month follow-up. The maintenance of achieved
improvements after the discontinuation of physiotherapy treatment is a main goal [16]. Our results
corroborate those from Borello-France et al. [17], who described that the improvements reached after
an intensive PFMT program in women with stress UI were sustained over a six-month follow-up
period. Our adherence rate was high in all three groups, where 60%–70% of women reported that
they continued PFM training at least weekly, and 85% claimed to perform the knack manoeuvre when
necessary. In long-term studies 1 to 5 years after an intensive physiotherapy treatment, PFM strength
and reduced symptoms were maintained, and were attributed to the fact that 70% of women continued
to exercise their PFMs at least once a week [35]. However, it has been reported that 15 years after PFMT
intervention, adherence drops to 28% and benefits are not maintained [36]. Our positive results in
a medium-term follow-up may have been attributed to the intensive, positive result of exercise and
the continuation of the knack during tasks that increase intra-abdominal pressure [37]. A limitation
of this study was that adherence was self-reported by the participants to the study physiotherapist,
and was reported dichotomously. Women may indeed have performed exercises, but at a much
lower frequency and intensity than prescribed, or may have reported that they were still performing
the exercises because that is what they thought the physiotherapist would want to hear. In order
to improve adherence, it would be required to address in depth the difficulties and the reasons that
generate that some patients continue, and others do not persist in practicing home exercises.
A final limitation to consider in interpreting the study findings is that the PFMT-G and PFMT+HE-G
groups were more familiar with the instruments used to assess PFM strength and basal tone at the
follow up assessment than the HE-G, since they were used in the treatment protocol. However, this did
not appear to be a problem, since PFM strength and tone were deemed to have improved in all group,
and regardless, the primary outcome variables were related to symptoms and quality of life.
5. Conclusions
Multi-modal physiotherapy treatments based on PFMT, HE, or both, and all including an
educational program, the knack manoeuvre and home exercises, significantly reduced PFD symptoms,
enhanced quality of life and improved PFM strength and tone among women with different
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combinations of mild symptoms of pelvic floor dysfunction, including stress or mixed UI, AI and/or
POP (stages I–II). Improvements were sustained up to 12 months later, where 53% of participants
reported continued adherence to the home exercises and 78% continued to incorporate the knack
manoeuvre into their activities of daily life.
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